FindTrial
Sign In

Proteasome Inhibitor

DRUG3 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, Sung-Soo Park

Conditions

Burkitt LymphomaDiffuse Large B Cell Lymphoma RelapsedHigh Grade B-cell LymphomaMultiple MyelomaMultiple Myeloma (MM)Multiple Myeloma, RelapsedPrimary Mediastinal Large B-Cell LymphomaRelapsed/refractory High Grade B Cell Lymphoma

Unknown Phase

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Active, not recruitingNCT05271630
H. Lee Moffitt Cancer Center and Research InstituteMultiple Myeloma
Start: 2022-04-20End: 2026-12-01Updated: 2026-03-02
Immunotherapy in Lymphoma
RecruitingNCT06796517
Sung-Soo ParkBurkitt Lymphoma, Diffuse Large B Cell Lymphoma Relapsed, High Grade B-cell Lymphoma +2
Start: 2024-06-26End: 2025-12-31Target: 72Updated: 2025-01-28
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
RecruitingNCT07051850
Sung-Soo ParkMultiple Myeloma (MM), Multiple Myeloma, Relapsed
Start: 2025-07-14End: 2025-12-31Target: 174Updated: 2025-07-15